---

Rhino-orbito-Cerebral mucormycosis during COVID 19 pandemic in western Uttar Pradesh India

---

Original Article

Author Details : Keshav Gupta, Mohit Srivastava*, Veenita Singh

Volume : 4, Issue : 3, Year : 2021

Article Page : 94-97

https://doi.org/10.18231/j.ijoas.2021.019

Suggest article by email

Get Permission

---

Abstract

Mucormycosis (Black fungus) is a designated as a rare, rapidly progressive fatal disease of immunocompromised caused by saprophytic fungus of family mucorales. Early diagnosis with prompt medical and surgical treatment is the only tool available. Rhino-orbito-cerebral is the most common subtype. In India we saw a sudden rise in mucormycosis cases during second wave of COVID 19. This necessitated a systematic review of epidemic of mucormycosis in COVID 19.A Retrospective multi-centric study was conducted comprising of 51 cases of Rhino-orbito-cerebral mucormycosis with present or recent COVID19 in Western Uttar Pradesh positive status presenting to us during 14 April 2021- 31 May 2021.Either Type2 Diabetes Mellitus or history of recent use of steroids in high doses was present in all the patients. Contribution of virulence of the Delta strain B1.617.2 is significant. FESS with sino-nasal debridement contributes significantly towards mortality reduction and cost of total treatment by significantly reducing days of Liposomal Amphotericin B therapy.Early diagnosis with prompt medical and surgical management along with blood sugar control and avoiding use of high dose of steroids remain to key to mortality and morbidity reduction.

Keywords: Black fungus, mucor, mucormycosis, rhino­orbito­cerebral, causes, treatment, covid 19, India, sugar, steroids, steam, oxygen, surgery

How to cite : Gupta K, Srivastava M, Singh V, Rhino-orbito-Cerebral mucormycosis during COVID 19 pandemic in western Uttar Pradesh India. J Otorhinolaryngol Allied Sci 2021;4(3):94-97

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.